Boston Scientific Gains Approval Of Taxus Atom Stent For Small Vessels
This article was originally published in The Gray Sheet
Executive Summary
FDA approval for two Boston Scientific Taxus Express2 stents signals the firm is finally coming out from under the company-wide warning letter that has prevented it from launching new products, and suggests the agency will soon approve its next-generation Liberté paclitaxel-eluting stent